Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study.

MedStar author(s):
Citation: BMC Infectious Diseases. 14:572, 2014.PMID: 25358621Institution: MedStar Washington Hospital CenterDepartment: Medicine/Pulmonary-Critical CareForm of publication: Journal ArticleMedline article type(s): Journal Article | Research Support, Non-U.S. Gov'tSubject headings: *Acinetobacter Infections/mo [Mortality] | *Bacteremia/mo [Mortality] | *Hospital Mortality | Acinetobacter Infections/dt [Drug Therapy] | Acinetobacter/ip [Isolation & Purification] | Adult | Age Factors | Aged | Aged, 80 and over | Anti-Bacterial Agents/tu [Therapeutic Use] | Bacteremia/dt [Drug Therapy] | Carbapenems/tu [Therapeutic Use] | Drug Resistance, Bacterial | Female | Humans | Intensive Care Units | Male | Microbial Sensitivity Tests | Middle Aged | Multivariate Analysis | Odds Ratio | Respiration, Artificial | Retrospective Studies | Risk Factors | Severity of Illness IndexYear: 2014Local holdings: Available online from MWHC library: 2001 - presentISSN:
  • 1471-2334
Name of journal: BMC infectious diseasesAbstract: BACKGROUND: We hypothesized that among septic ICU patients with Acinetobacter spp. bacteremia (Ac-BSI), carbapenem-resistant Acinetobacter spp. (CRAc) increase risk for inappropriate initial antibiotic therapy (non-IAAT), and non-IAAT is a predictor of hospital death.CONCLUSIONS: Among septic ICU patients with Ac-BSI, non-IAAT predicts mortality. Carbapenem resistance appears to mediate the relationship between non-IAAT and mortality.METHODS: We conducted a retrospective cohort study of adult septic ICU patients with Ac-BSI. Non-IAAT was defined as exposure to initially prescribed antibiotics not active against the pathogen based on in vitro susceptibility testing, and having no exposure to appropriate antimicrobial treatment within 24 hours of drawing positive culture. We compared patients who died to those who survived, and derived regression models to identify predictors of hospital mortality and of non-IAAT.RESULTS: Out of 131 patients with Ac-BSI, 65 (49.6%) died (non-survivors, NS). NS were older (63 [51, 76] vs. 56 [45, 66] years, p=0.014), and sicker than survivors (S): APACHE II (24 [19, 31] vs. 18 [13, 22], p<0.001) and Charlson (5 [2, 8] vs. 3 [1, 6], p=0.009) scores. NS were also more likely than S to require pressors (75.4% vs. 42.4%, p<0.001) and mechanical ventilation (75.4% vs. 53.0%, p=0.008). Both CRAc (69.2% vs. 47.0%, p=0.010) and non-IAAT (83.1% vs. 59.1%, p=0.002) were more frequent among NS than S. In multivariate analyses, non-IAAT emerged as an independent predictor of hospital death (risk ratio [RR] 1.42, 95% confidence interval [CI] 1.10-1.58), while CRAc was the single strongest predictor of non-IAAT (RR 2.66, 95% CI 2.43-2.72).All authors: Kollef MH, Micek ST, Shorr AF, Zilberberg MDFiscal year: FY2015Digital Object Identifier: Date added to catalog: 2016-01-13
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 25358621 Available 25358621

Available online from MWHC library: 2001 - present

BACKGROUND: We hypothesized that among septic ICU patients with Acinetobacter spp. bacteremia (Ac-BSI), carbapenem-resistant Acinetobacter spp. (CRAc) increase risk for inappropriate initial antibiotic therapy (non-IAAT), and non-IAAT is a predictor of hospital death.

CONCLUSIONS: Among septic ICU patients with Ac-BSI, non-IAAT predicts mortality. Carbapenem resistance appears to mediate the relationship between non-IAAT and mortality.

METHODS: We conducted a retrospective cohort study of adult septic ICU patients with Ac-BSI. Non-IAAT was defined as exposure to initially prescribed antibiotics not active against the pathogen based on in vitro susceptibility testing, and having no exposure to appropriate antimicrobial treatment within 24 hours of drawing positive culture. We compared patients who died to those who survived, and derived regression models to identify predictors of hospital mortality and of non-IAAT.

RESULTS: Out of 131 patients with Ac-BSI, 65 (49.6%) died (non-survivors, NS). NS were older (63 [51, 76] vs. 56 [45, 66] years, p=0.014), and sicker than survivors (S): APACHE II (24 [19, 31] vs. 18 [13, 22], p<0.001) and Charlson (5 [2, 8] vs. 3 [1, 6], p=0.009) scores. NS were also more likely than S to require pressors (75.4% vs. 42.4%, p<0.001) and mechanical ventilation (75.4% vs. 53.0%, p=0.008). Both CRAc (69.2% vs. 47.0%, p=0.010) and non-IAAT (83.1% vs. 59.1%, p=0.002) were more frequent among NS than S. In multivariate analyses, non-IAAT emerged as an independent predictor of hospital death (risk ratio [RR] 1.42, 95% confidence interval [CI] 1.10-1.58), while CRAc was the single strongest predictor of non-IAAT (RR 2.66, 95% CI 2.43-2.72).

English

Powered by Koha